GlassScriptPhysician profile
Qiong Wu
NPI 1992763916
$7,610.45
in general payments reported to CMS, 2019-2025
9 companies · $667 in 2025
The $667 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,660 · 2020: $267 · 2021: $431 · 2022: $1,213 · 2023: $668 · 2024: $706 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,040.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $6,669.97 | 2019-2025 | Vemlidy |
| Novo Nordisk INC | $375.00 | 2022 | |
| Madrigal Pharmaceuticals | $141.62 | 2025 | Rezdiffra |
| Allergan, INC. | $125.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2025 | |
| Janssen Pharmaceuticals, INC | $103.37 | 2019 | |
| Iridex Corporation | $38.18 | 2019 | |
| Abbvie INC. | $18.75 | 2023 | Botox |
| Amarin Pharma, INC. | $13.56 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Qiong Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.